State Street Corp Precision Biosciences Inc Transaction History

State Street Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.7 - $1.41 $15,749 - $31,725	22,500 Added 10.14%	244,349 $183,000
Q4 2022 Feb 14, 2023	BUY	$0.97 - $45.0 $54,029 - $2.51 Million	55,700 Added 33.52%	221,849 $264,000
Q2 2022 Aug 15, 2022	SELL	$1.15 - $3.34 $1.25 Million - $3.64 Million	-1,089,637 Reduced 86.77%	166,149 $266,000
Q1 2022 May 16, 2022	SELL	$2.96 - $7.76 $4.63 Million - $12.1 Million	-1,562,921 Reduced 55.45%	1,255,786 $3.87 Million
Q4 2021 Feb 14, 2022	BUY	$7.4 - $11.66 $2.11 Million - $3.32 Million	285,070 Added 11.25%	2,818,707 $20.9 Million
Q3 2021 Nov 15, 2021	SELL	$9.18 - $14.15 $2.32 Million - $3.58 Million	-252,824 Reduced 9.07%	2,533,637 $29.2 Million
Q2 2021 Aug 16, 2021	SELL	$8.07 - $12.52 $19.1 Million - $29.6 Million	-2,362,298 Reduced 45.88%	2,786,461 $34.9 Million
Q1 2021 May 17, 2021	BUY	$8.57 - $15.79 $22 Million - $40.5 Million	2,562,843 Added 99.11%	5,148,759 $53.3 Million
Q4 2020 Feb 16, 2021	BUY	$5.98 - $12.47 $10.8 Million - $22.6 Million	1,813,567 Added 234.81%	2,585,916 $21.6 Million
Q3 2020 Nov 10, 2020	BUY	$4.65 - $8.73 $46,751 - $87,771	10,054 Added 1.32%	772,349 $4.76 Million
Q2 2020 Aug 14, 2020	BUY	$4.66 - $8.7 $745,837 - $1.39 Million	160,051 Added 26.58%	762,295 $6.35 Million
Q1 2020 May 11, 2020	BUY	$5.05 - $15.01 $3.04 Million - $9.04 Million	602,244 New	602,244 $3.63 Million

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $554M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.